V
70
4
FSLR
63
5
SPG
55
4
DHR
52
11
DHI
52
8
FLS
56
6
WMT
60
-6
ACN
38
-2
PHM
63
5
THC
73
2
MAC
71
4
A
44
4
FRT
53
2
MDLZ
85
6
PPL
57
-2
GOOGL
66
2
EXPD
42
-3
DFS
68
3
VIX
49
-12
ADT
25
2
V
70
4
FSLR
63
5
SPG
55
4
DHR
52
11
DHI
52
8
FLS
56
6
WMT
60
-6
ACN
38
-2
PHM
63
5
THC
73
2
MAC
71
4
A
44
4
FRT
53
2
MDLZ
85
6
PPL
57
-2
GOOGL
66
2
EXPD
42
-3
DFS
68
3
VIX
49
-12
ADT
25
2
Financhill
Back

Rhythm Pharmaceuticals 10K Form

Buy
56

RYTM
Rhythm Pharmaceuticals

Last Price:
39.81
Seasonality Move:
8.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYTM News And Ratings

See the #1 stock for the next 7 days that we like better than RYTM

RYTM Financial Statistics

Sales & Book Value

Annual Sales: $77.43M
Cash Flow: $-29.38M
Price / Cash Flow: 0
Annual Sales: $2.86
Price / Book: 14.17

Profitability

EPS (TTM): -3.20000
Net Income (TTM): $-184.68M
Gross Margin: $68.13M
Return on Equity: -89.34%
Return on Assets: -53.53%

Rhythm Pharmaceuticals Earnings Forecast

Key Rhythm Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for RYTM is 87.99%.
  • The Selling, General & Administrative Expenses for RYTM have been equal to 151.80% of Gross Profit Margin.
  • The Research & Development expenses have been 174.29% of Revenue.
  • The Interest Expense is -7.52% of Operating Income.
  • The Net Earning history of RYTM is -238.52% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Rhythm Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RYTM
CUSIP: 76243J
Website: rhythmtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.58
Quick Ratio: 5.27

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYTM Technical Analysis vs Fundamental Analysis

Buy
56
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy or a Sell?